Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecruitment status indicates the study is no longer enrolling participants. The page now includes new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a revision label (Revision: v3.6.0).SummaryDifference0.3%

- Check15 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the study documentation has been published.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.5.4 replaces the previous Revision: v3.5.3 on this page, indicating a new version of the study record. This update reflects minor edits or clarifications to the document rather than changes to the study content itself.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page’s displayed release/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check65 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check72 days agoChange DetectedItaly location entry updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.SummaryDifference0.0%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.